Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00575016 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
74
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to enrollment challenges.

Conditions

Interventions

Sponsor

Allergan